tiprankstipranks
Zomedica Pharmaceuticals (ZOM)
:ZOM
US Market

Zomedica Pharmaceuticals (ZOM) Income Statement

Compare
4,753 Followers

Zomedica Pharmaceuticals Income Statement

Last quarter (Q3 2025), Zomedica Pharmaceuticals's total revenue was $7.00M, an increase of 10.24% from the same quarter last year. In Q3, Zomedica Pharmaceuticals's net income was $-6.70M. See Zomedica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.19M$ 18.93M$ 4.13M$ 0.00$ 0.00
Gross Profit
$ 17.32M$ 13.65M$ 3.05M$ -530.02K$ -787.61K
Operating Expenses
$ 48.91M$ 35.58M$ 24.43M$ 16.76M$ 19.78M
Depreciation and Amortization
$ 6.30M$ 4.04M$ 1.14M$ 530.02K$ 787.61K
EBITDA
$ -29.39M$ -15.34M$ -19.57M$ -16.38M$ -19.00M
Operating Income
$ -31.59M$ -21.92M$ -21.37M$ -16.76M$ -19.78M
Other Income/Expenses
$ -4.27M$ 2.54M$ 657.78K$ -146.81K$ 273.00
Pretax Income
$ -35.86M$ -19.38M$ -20.72M$ -16.91M$ -19.78M
Net Income
$ -34.53M$ -17.02M$ -18.38M$ -16.92M$ -19.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.04$ -0.02$ -0.02$ -0.05$ -0.19
Diluted EPS
$ -0.04$ -0.02$ -0.02$ -0.05$ -0.19
Weighted Average Shares Outstanding
979.95M 979.92M 956.53M 364.44M 106.30M
Weighted Average Shares Outstanding (Diluted)
979.95M 979.92M 956.53M 364.44M 106.30M
Currency in USD

Zomedica Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis